P87 Comparison of a voclosporin-based, triple immunotherapy regimen to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV plus AURORA 1 studies and ALMS

• Kenneth Kalunian,
• Maria Dall’Era,
• Anca Askanase,
• Neil Solomons,
• Matt Truman,
• Lucy Hodge,
• Ernie Yap

Affiliations

Kenneth Kalunian

Division of Rheumatology, Allergy and Immunology, University of California San Diego School of Medicine, San Diego, California, USA

Maria Dall’Era

2Dept. of Medicine, Columbia University Medical Center, New York, USA

Anca Askanase

3 Department of Rheumatology, Columbia University Irving Medical Center, New York, New York, USA

Neil Solomons

Aurinia Pharmaceuticals Inc, Victoria, British Columbia, Canada

Matt Truman

Aurinia Pharmaceuticals Inc, Victoria, British Columbia, Canada

Lucy Hodge

2Dept. of Medicine, Columbia University Medical Center, New York, USA

Ernie Yap

2Dept. of Medicine, Columbia University Medical Center, New York, USA